23 Mar

Staunch critic of Big Pharma IP strategies confirmed as US Health Secretary

The newly appointed Xavier Becerra will push for HHS policies less favourable to patent-owning companies, but industry watchers must wait for more signals to get the measure of the Biden administration’s pharma IP strategy.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth